N van Es, M Di Nisio, G Cesarman, A Kleinjan… - …, 2017 - ncbi.nlm.nih.gov
In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous thromboembolism is not recommended. Several risk prediction scores to identify cancer …
Cancer patients are at increased risk of developing venous thromboembolism (VTE). Guidelines recommend routine thromboprophylaxis in hospitalised acutely ill cancer …
Rates of venous thromboembolism (VTE) vary substantially between cancer patients. Multiple clinical risk factors including primary site of cancer and systemic therapy, and …
AA Khorana, GC Connolly - Journal of Clinical Oncology, 2009 - ascopubs.org
Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE). Rates of VTE, however, vary markedly among patients with cancer. Design This review …
NM Kuderer, E Culakova, GH Lyman, C Francis… - The …, 2016 - academic.oup.com
Background. Retrospective studies have suggested an association between cancer- associated venous thromboembolism (VTE) and patient survival. We evaluated a previously …
The Khorana score is recommended for guiding primary venous thromboembolism (VTE) prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
AA Khorana, CW Francis - Thrombosis research, 2018 - Elsevier
Cancer-associated venous thromboembolism (VTE) has major consequences for patients, including morbidity and risk of mortality. However, there is substantial variation in risk …
Patients with cancer are heterogeneous concerning the risk for VTE. Some solid malignancies including pancreatic, lung, colon-rectum, ovarian, and brain cancer are …
The Asian population is thought to have a low risk of venous thromboembolism (VTE), but the epidemiology of VTE in cancer patients remains unclear. The National Health Insurance …